Galway medtech Endowave raising €5m for game-changing lung cancer treatment
The firm’s microwave ablation device is ready for first in-human clinical study
Endowave, which is developing a new device to treat lung cancer, is currently raising €5m in its first round of equity to complete a first in-human clinical study of its technology.
The Galway based company, founded in 2018, is working to develop a minimally invasive device which uses microwave energy to treat the disease. It is hoped the device will help treat the 85 per cent or so of lung cancer patients who are ineligible ...